CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 8-K Event Executive or director change · Code of ethics change
- 4 Grant or award 10% owner acquired 12,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 18,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,000 shares at $3.34 ($16,684)
- 4 Open-market buy Director bought 5,000 shares at $3.65 ($18,242)
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 5,000 shares at $4.00 ($19,996)
- 4 Open-market buy Director bought 10,000 shares at an average $4.25 ($42,493)
- 4 Open-market buy Director bought 10,000 shares at an average $4.47 ($44,695)
Page 26 of 63 · 1,250 filings